{"url_path":"/sec/mrmd/8-k/2026-05-13/item-2-02","section_key":"item-2-02","section_title":"Item 2.02 Results of Operations and Financial Condition.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1522767/0001522767-26-000070-index.html","accession_number":"0001522767-26-000070","cik":"0001522767","ticker":"MRMD","issuer_name":"MARIMED INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1522767/0001522767-26-000070-index.html","primary_entity_key":"0001522767","primary_entity_name":"MARIMED INC."},"word_count":48,"has_tables":true,"body_markdown":"Item 2.02. Results of Operations and Financial Condition.\n\nOn May 13, 2026, MariMed Inc. (the “Company”) issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference, announcing its financial results for the three-month period ended March 31, 2026."}